Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Report
Case Report
Case Series
Editorial
Focus
Images/Instrument in Dermatology/Dermatosurgery
Innovations
Letter to the Editor
Living Legends
Looking back in history
Original Article
Perspective
Resident Forum
Review Article
Spot the Diagnosis
Tropical Dermatology
Visual Treats in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Report
Case Report
Case Series
Editorial
Focus
Images/Instrument in Dermatology/Dermatosurgery
Innovations
Letter to the Editor
Living Legends
Looking back in history
Original Article
Perspective
Resident Forum
Review Article
Spot the Diagnosis
Tropical Dermatology
Visual Treats in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Report
Case Report
Case Series
Editorial
Focus
Images/Instrument in Dermatology/Dermatosurgery
Innovations
Letter to the Editor
Living Legends
Looking back in history
Original Article
Perspective
Resident Forum
Review Article
Spot the Diagnosis
Tropical Dermatology
Visual Treats in Dermatology
View/Download PDF

Translate this page into:

Visual Treats in Dermatology
2025
:5;
26
doi:
10.25259/CSDM_3_2025

Telangiectatic mats in systemic sclerosis

Department of Dermatology, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India.
Author image

*Corresponding author: Manju Daroach, Department of Dermatology, All India Institute of Medical Sciences, Bilaspur, Chhattisgarh, India. daroachmanju@gmail.comm

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Dhiman A, Daroach M. Telangiectatic mats in systemic sclerosis. CosmoDerma. 2025;5:26. doi: 10.25259/CSDM_3_2025

A 54-year-old female known case of proximal systemic sclerosis (having skin thickening proximal to elbows, knees, and trunk, digital pitted scars, Raynaud’s history with positive anti-topoisomerase antibodies) for five years referred from the rheumatology outpatient department with multiple reddish lesions over the face and palms for the past five months. On examination, there were multiple mat-like telangiectasias over the face [Figure 1a and b] and bilateral palms [Figure 1c]. Telangiectatic mats or mat-like telangiectasia, characterized by flat, macular clusters of uniform small vessels around 0.5 cm in size, usually appear in rectangular formations. These are most often observed on the face, lips, palms, and the backs of the hands and can also be found around the lips, tongue, and mucous membranes. The presence of cutaneous telangiectasias indicates ongoing vascular damage and may act as a useful clinical biomarker for systemic vascular abnormalities, including pulmonary vascular disease, which has the potential to progress to pulmonary arterial hypertension (PAH). A higher number of telangiectasia is associated with an increased risk of PAH in patients with scleroderma.[1]

(a) Mat-like telangiectasia over the face, inset showing dilated capillary. (b) Mat-like telangiectasia over the left side of the face. (c) Mat-like telangiectasia over palms bilaterally.
Figure 1:
(a) Mat-like telangiectasia over the face, inset showing dilated capillary. (b) Mat-like telangiectasia over the left side of the face. (c) Mat-like telangiectasia over palms bilaterally.

Ethical approval

Institutional Review Board approval is not required.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , , . Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension. J Rheumatol. 2010;37:98-104.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
78

PDF downloads
0
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections